TransCon PTH

Designed to replace parathyroid hormone to physiologic levels in patients with hypoparathyroidism

Designed to replace parathyroid hormone to physiologic levels in patients with hypoparathyroidism

Vector-Smart-Object-copy

A survey of people living with hypoparathyroidism (N=146) showed patients required multiple physician visits and up to one decade to diagnose their condition.

Explore

You are about to access www.ascendispharma.us, which includes information intended for U.S. residents only. Click below to confirm.

Are you a U.S. resident?

If so, please confirm below to proceed to our U.S. website. If not, continue to our global website.